3 results
The primary objective of the research is to find out if treatment with BMS-931699 can improve systemic lupus erythematosus (SLE) disease activity. This will be measured by determining the proportion of BICLA responders who achieve BILAG disease…
1) To compare gait quality in daily life and challenging gait skills of patients 1 year following cruciate-retaining TKA compared to a healthy, age and gender matched cohort.2) To compare pre- to post-operative cruciate TKA status in quantity and…
Primary objective: To assess the efficacy of T-DXd relative to platinum with pemetrexed plus pembrolizumab by assessment of PFS by BICR in participants with unresectable, locally advanced, or metastatic NSCLC harboring HER2 exon 19 or 20 mutations.